Please login to the form below

Not currently logged in
Email:
Password:

SO Patient

This page shows the latest SO Patient news and features for those working in and with pharma, biotech and healthcare.

British Business Bank sets up £2.5bn fund for ‘unicorn’ firms

British Business Bank sets up £2.5bn fund for ‘unicorn’ firms

British Patient Capital - which was pledged by Chancellor Philip Hammond last autumn and run by the British Business Bank - aims to support companies with high-growth potential and plug the deficit ... So, British Patient Capital will provide an extra £2

Latest news

  • Daily Brief: GDPR and NHS Opt Out Day, BioMarin's new rare disease approval and more Daily Brief: GDPR and NHS Opt Out Day, BioMarin's new rare disease approval and more

    That means Mylotarg isn’t recommended for people whose disease has intermediate cytogenetic status, and Pfizer says this will exclude around 65% of the eligible patient population  the provisional recommendation. ... Craig Eagle, Head of Oncology,

  • The power of pharma businesses to drive social change The power of pharma businesses to drive social change

    As a company we are focused on addressing unmet patient needs, so we chose to support the Fistula Foundation because obstetric fistula is a key, unmet health need where we knew

  • Signal strength Signal strength

    So how do you make communications that not only sing, they make your customers dance to your tune? ... If you do not start there, you’ll never create communications that truly improve patient outcomes.”.

  • Janssen launches UK blood cancer awareness campaign Janssen launches UK blood cancer awareness campaign

    The Make Blood Cancer Visible campaign coincides with blood cancer awareness month and is backed by nine blood cancer patient support groups. ... We are therefore delighted to be a part of this exciting campaign helping to raise awareness of blood cancer

  • Healthcare in the digital age Healthcare in the digital age

    In doing so it radically altered the doctor-patient relationship and conversations between the two about healthcare, but it was not without its challenges. ... How does it relate to a better outcome and how could it increase productivity in the hospital

More from news
Approximately 1 fully matching, plus 122 partially matching documents found.

Latest Intelligence

  • ‘How is your day?’ ‘How is your day?’

    Plasma-treatable conditions have a small patient population, so the issue for plasma protein therapies is smaller patient numbers, coupled with a supply and production process that is far more complex ... Secondly, building strong links between donor and

  • GDPR and the NHS ‘opt out’: a chance to engage patients in research GDPR and the NHS ‘opt out’: a chance to engage patients in research

    Naomi Boxall adds: “Our responsibility then, as researchers, is to provide access to published research which illustrates why patient participation is so important. ... In so doing, the patient’s input becomes invaluable in medical research, as the

  • We can be heroes We can be heroes

    1. Clear, patient-focused objectives, explicitly agreed and documented. 2. A shared commitment to common goals. ... Collaboration is  a highly effective way for pharma to put patient-centricity into practice, so that everybody involved can feel proud

  • Pharma’s isolated islands of innovation Pharma’s isolated islands of innovation

    so far largely resulted in isolated islands of innovation that remain unconnected from the average patient’s perspective. ... So even in our brutally and artificially simple example, we’re not designing around the patient at all.

  • Beyond caring: learning from the unsung advocates in cancer care

    So perhaps unsurprisingly being labelled as a ‘carer’doesn’t strike a chord among people who care. ... Advocates obviously play a critical and diverse role in a patient’s cancer care, but with so many challenges to overcome, at such a difficult

More from intelligence
Approximately 0 fully matching, plus 41 partially matching documents found.

Latest appointments

  • Ferring appoints executive VP and chief medical officer Ferring appoints executive VP and chief medical officer

    Michel Pettigrew, president of the executive board and chief operating officer, Ferring Pharmaceuticals, said: “Making the industry more patient-centric has always been a top priory for Professor Dugi, and this ... is perfectly aligned with our

  • Sanofi appoints ‘chief patient officer’ Sanofi appoints ‘chief patient officer’

    The company explained that Dr Beal will be tasked with elevating the 'perspective of the patient within Sanofi so the company's future healthcare offerings can better incorporate the unique priorities ... the patient perspective advances our approach to

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Wearables and Healthcare

    to healthcare providers more regularly, actively research aspects of their own healthcare, and join patient portals.[6]. ... London: The King’ s Fund; 2014. 6. The 2017 Patient Engagement Perspectives Study.

  • Device Attribute Testing

    The patient evaluation needed to reflect real life as much as possible, so that it truly reflected patient preference and could predict the future market impact of any new device.

  • PMEA win for TVF Communications and AbbVie Healthcare!

    for our joint effort with AbbVie in the development of ‘ The Story of HS: A Patient Journey’. ... With the addition of pre and post assessment, this was an excellent patient-centred approach to training compared to approaches normally taken.”.

  • Seven ways that digital has changed pharma marketing

    Today data is driving agile processes that enable us to respond faster to market realities and do so at scale. ... Increased patient knowledge. Not so long ago, people had very little information about their condition or the treatment options available.

  • Biosimilars: Getting the flock to market

    So biosimilars not only increase patient access to tried and trusted biologics, they may accelerate adoption of new agents. ... But with so many new entrants flocking to join, the biosimilar field is about to become very crowded.

More from PMHub
Approximately 0 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics